Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been...
Hence then, the article about globally significant opportunity emerges as remplir is used in nerve sparing prostate cancer surgery was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery )
Also on site :
- Saratoga® Spring Water Steps Beyond the Bottle and onto the Runway with Public School New York Collaboration
- Superfood Gummies Are a ‘Game Changer’ for Picky Kids, and We Found Some Packed With Essential Nutrients
- Blue Bell Just Announced Its New Coffee-Inspired Ice Cream Flavor—And It’s Heading to Stores This Week